2013 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/19/13West Announces First-Quarter 2014 Dividend
EXTON, PA -- (Marketwired) -- 12/19/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a first-quarter 2014 cash dividend of $0.10 per share. The dividend will be paid on February 5, 2014 to shareholders of record on January 22, 2014. About West West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliab... 
Printer Friendly Version
11/07/13West Completes Preliminary Study Evaluating the SmartDose Electronic Patch Injector Technology Platform, Which Incorporates a Daikyo Crystal Zenith Cartridge
EXTON, Pa., Nov. 7, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed a preliminary study of its SmartDose® technology platform, which incorporates a Daikyo Crystal Zenith® (CZ) cartridge. The study evaluated multiple attributes of the technology and subjects' experience with the self-application process. (Logo: http://photos.prnewswire.com/prnh/20131029/NE05658LOGO ) The June 2013... 
Printer Friendly Version
11/01/13West to Co-present Research Findings on Understanding the Patient Journey through the Phases of a Chronic Disease
Understanding user needs is critical to improved patient outcomes EXTON, Pa., Nov. 1, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed primary user research with its partner, Insight Product Development, aimed at understanding the needs of patients, caregivers and clinicians in the field of injectable therapies for chronic diseases. West will co-present a poster summarizing the find... 
Printer Friendly Version
10/31/13West Announces Third Quarter 2013 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 10/31/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2013. In addition, West updated its financial guidance for the year, estimated its sales growth range for 2014, and updated its long-term planning objectives. Third Quarter Highlights Sales grew 12.5% compared to third quarter 2012 (10.9% excluding currency effects) Adj... 
Printer Friendly Version
10/29/13Peer-Reviewed Study Proves Effectiveness of Crystal Zenith® Container Closure Systems for Radiopharmaceuticals
EXTON, Pa., Oct. 29, 2013 /PRNewswire/ -- West (NYSE: WST), a leading global manufacturer of components and systems for injectable drug delivery, today announced the first peer-reviewed data demonstrating the benefits of Daikyo Crystal Zenith vials for the synthesis of radiopharmaceutical products. The study, conducted by researchers from Massachusetts General Hospital's Division of Nuclear Medicine and Molecular Imaging, compared the effectiveness of container closure systems made from the Daik... 
Printer Friendly Version
10/24/13West to Host Third Quarter 2013 Conference Call
EXTON, PA -- (Marketwired) -- 10/24/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter 2013 financial results before the market opens on Thursday, October 31, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 20596408. A live broadcast of the conference call will be... 
Printer Friendly Version
09/04/13West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 09/04/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: Morgan Stanley 2013 Global Healthcare Conference, New York, NY Wednesday, September 11, 2013 at 10:35 AM Eastern Time. CL King's 11th Annual Best Ideas Conference, New York, NY Thursday,... 
Printer Friendly Version
08/01/13West Announces Second Quarter 2013 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 08/01/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2013 and updated its financial guidance for the year. Second Quarter Highlights Sales grew 6.1% compared to second quarter 2012 (5.7% excluding currency) Diluted EPS was $0.86 per share Raises 2013 adjusted diluted EPS guidance to between $3.10 and $3.25... 
Printer Friendly Version
08/01/13West Announces Stock Split and Raises Quarterly Dividend
EXTON, PA -- (Marketwired) -- 08/01/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) ("West") today announced that the Company's Board of Directors has approved a two-for-one split of the Company's common stock to be effected through a stock dividend. West also announced an increase in the quarterly cash dividend for the twenty-first consecutive year, by $0.01 per share (on a pre-split basis). The record date for the stock split is the close of business on September 12, 2013, with share d... 
Printer Friendly Version
07/24/13West to Host Second Quarter 2013 Conference Call
EXTON, PA -- (Marketwired) -- 07/24/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release second quarter 2013 financial results before the market opens on Thursday, August 1, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-318-8613 (U.S.) or 617-399-5132 (International). The passcode is 88976013. A live broadcast of the conference call will be ... 
Printer Friendly Version
07/02/13West Expands NovaGuard™ Platform of Products for Safe and Effective Injectable Drug Delivery
West's NovaGuard systems help keep healthcare workers and patients safe from needlestick injuries EXTON, Pa., July 2, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products. The NovaGuard SA (Staked-needle Automatic) system, formerly called the B.Safe syringe system technology, is now part of the ... 
Printer Friendly Version
06/20/13West to Celebrate 90 Years of Healthcare Innovation at the NYSE
Chairman and CEO Gavels Today's Trading Session to a Close EXTON, Pa., June 20, 2013 /PRNewswire/ -- Today, representatives from West Pharmaceutical Services, Inc. (NYSE: WST), will celebrate the company's 90th anniversary by ringing the closing bell at the New York Stock Exchange. The closing ceremony at the stock exchange commemorates West's long history of working side-by-side with top pharmaceutical, biotechnology and medical device companies around the globe to solve the challenges of ... 
Printer Friendly Version
05/10/13West Announces Third-Quarter 2013 Dividend
EXTON, PA -- (Marketwired) -- 05/10/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a third-quarter 2013 cash dividend of $0.19 per share. The dividend will be paid on August 7, 2013 to shareholders of record on July 24, 2013. About West West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability... 
Printer Friendly Version
05/08/13West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 05/08/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in three upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: Bank of America Merrill Lynch 2013 Health Care Conference, Las Vegas, NV Wednesday, May 15, 2013 at 1:00 PM Pacific Time. UBS 2013 Global Healthcare Conference, New York, NY Wednesday,... 
Printer Friendly Version
05/02/13West Announces First Quarter 2013 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 05/02/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2013 and increased its earnings-per-share (EPS) guidance for the year. First-Quarter Highlights Sales grew 7.3% vs. first quarter 2012 GAAP EPS of $0.90 Adjusted diluted EPS of $0.87 Raises full-year 2013 adjusted diluted EPS guidance to bet... 
Printer Friendly Version
04/24/13West to Host First Quarter 2013 Conference Call
EXTON, PA -- (Marketwired) -- 04/24/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release first quarter 2013 financial results before the market opens on Thursday, May 2, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-515-2911 (U.S.) or 617-399-5125 (International). The passcode is 14629585. A live broadcast of the conference call will be avai... 
Printer Friendly Version
04/15/13West Celebrates 90 Years of Healthcare Innovation
World Leader in Drug Packaging and Delivery Evolves Alongside the Pharmaceutical and Biotechnology Industries to Forge a Healthier World EXTON, Pa., April 15, 2013 /PRNewswire/ -- Today, West Pharmaceutical Services, Inc. (NYSE: WST), a world leader in pharmaceutical and biotech drug packaging and delivery, celebrated the company's 90th anniversary. This landmark occasion commemorates West's long history of working side-by-side with top pharmaceutical and biotechnology companies around the ... 
Printer Friendly Version
03/15/13West Announces Second-Quarter 2013 Dividend
EXTON, PA -- (MARKETWIRE) -- 03/15/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a second-quarter 2013 cash dividend of $0.19 per share. The dividend will be paid on May 1, 2013 to shareholders of record on April 17, 2013. About West West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability a... 
Printer Friendly Version
03/07/13West to Present at Barclays Conference
EXTON, PA -- (MARKETWIRE) -- 03/07/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2013 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 14, 2013 at 9:30 AM Eastern Time. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westphar... 
Printer Friendly Version
02/27/13West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
Designed to help improve consistency and reliability of intradermal injections EXTON, Pa., Feb. 27, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces the commercial introduction of its ID Adapter. West acquired a license to the technology in 2010 and has completed the product development and first phase of commercial scale-up at its manufacturing center in Arizona... 
Printer Friendly Version
02/21/13West Announces Fourth Quarter and Full-Year 2012 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (MARKETWIRE) -- 02/21/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the 2012 fourth quarter and year. Fourth-Quarter Highlights Sales grew 8.8% (10.6% excluding currency) vs. fourth quarter 2011. GAAP diluted earnings per-share (EPS) of $0.60. Adjusted diluted EPS of $0.61, compared to $0.59 in prior-year period. Guides 2013 sale... 
Printer Friendly Version
02/13/13West to Host Fourth Quarter and Full Year 2012 Conference Call
LIONVILLE, PA -- (MARKETWIRE) -- 02/13/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release fourth quarter and full year 2012 financial results before the market opens on Thursday, February 21, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-573-4840 (U.S.) or 617-224-4326 (International). The passcode is 15317330. A live broadcast of the conf... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations